V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1) (pSer473) Antikörper

Antigen: V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1)

Synonyme: AKT, PKB, RAC, PRKBA, MGC99656, PKB-ALPHA, RAC-ALPHA, Akt, pkb, xAct, akt-1, v-akt, v-akt1, AKT1, AKT/PKB, D-Akt, DAKT1, DAKT1/PKB, DPKB, DRAC-PK, DRAC-PK66; DRAC-PK85, Dakt, PKB/AKT, PKB/dAKT, RacPK, dAKT/dPKB, dAkt/PKB, l(3)04226, l(3)89Bq, DmelCG4006, CG4006

Epitope: pSer473

Klonalität: Monoklonal (104A282)

Wirt: Maus

Reaktivität: Huhn, Human, Maus

Applikation: Western Blot (WB)

Produktnummer: ABIN121207

Produktbeschreibung

Weitere Bezeichnung: AKT1 / PKB pSer473

Swiss-Prot: P31749

Immunogen: Synthetic peptide containing phosphorylated serines at amino acid residues 473 of human Akt1

Isotyp: IgG1  (Passende Sekundärantikörper)

Klon: 104A282

Beschreibung: Akt, protein kinase B (PKB), is a serine/threonine kinase which is involved in many cellular signaling pathways and acts as a transducer of many functions initiated by growth factor receptors that activat phosphtidylinositol 3-kinase (PI 3-kinase). The major activity of Akt/PKB is to mediate cell survival. Akt/PKB is also believed to be a critical factor in the genesis of cancer as the tumor suppressor PTEN was found to antagonise PI-3 kinase and Akt/PKB kinase activity. Akt/PKB phosphorylation is critical for it activity. The major phosphorylation sites required for Akt activation has been identified as threoinine 308 and serine 473. Serine 473 is phosphorylated by MAPKAP kinase 2.

Spezifität: This monoclonal antibody was raised against a synthetic peptide containing phosphorylated serines at amino acid residues 473 of human Akt1 Accession no. ref|NP_005154.2| (see: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=Protein&list_uids=6224101 1&dopt=GenPept). Clone 104A282 detects specifically phosphorylated form of Akt1 expression in PDGF treated cells.

Synonyme: AKT, PKB, RAC, PRKBA, MGC99656, PKB-ALPHA, RAC-ALPHA, Akt, pkb, xAct, akt-1, v-akt, v-akt1, AKT1, AKT/PKB, D-Akt, DAKT1, DAKT1/PKB, DPKB, DRAC-PK, DRAC-PK66; DRAC-PK85, Dakt, PKB/AKT, PKB/dAKT, RacPK, dAKT/dPKB, dAkt/PKB, l(3)04226, l(3)89Bq, DmelCG4006, CG4006

Anwendungen

Applikationshinweise: Western blot: 2ug/ml. Immunoprecipitation: 1ug/ml. Recommended Positive Control : PDGF treated NIH 3T3. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.

Konzentration: 0.5 ml/ml

Buffer: PBS containing 0.2% gelatin, 0.05% sodium azide

Lagerung: Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf Life: 6 month from despatch.

Forschungsgebiet: Signaltransduktion, Phospho-Antikörper, Kinasen/Phosphatasen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Bilder

Western blot analysis for Akt1 using ABIN121207at 2 ug/ml dilution against 10 ug/lane of untreated (lane 1) and PDGF treated (lane 2) NIH-3T3 lysate

Publikationen

Publikationen: Alessi, Andjelkovic, Caudwell et al.: "Mechanism of activation of protein kinase B by insulin and IGF-1." in: The EMBO journal, Vol. 15, Issue 23, pp. 6541-51, 1997 (PubMed).

Franke, Kaplan, Cantley: "PI3K: downstream AKTion blocks apoptosis." in: Cell, Vol. 88, Issue 4, pp. 435-7, 1997 (PubMed).

Cantley, Neel: "New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, Issue 8, pp. 4240-5, 1999 (PubMed).

Kandel, Hay: "The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB." in: Experimental cell research, Vol. 253, Issue 1, pp. 210-29, 1999 (PubMed).